CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $16,999,000 | +21.2% | 4,497,042 | 0.0% | 0.78% | +44.6% |
| Q2 2018 | $14,031,000 | +25.1% | 4,497,042 | -4.2% | 0.54% | +0.7% |
| Q1 2018 | $11,215,000 | -26.3% | 4,692,343 | +20.6% | 0.54% | -45.6% |
| Q4 2017 | $15,219,000 | +30.3% | 3,892,343 | -16.0% | 0.99% | +8.8% |
| Q3 2017 | $11,682,000 | +11.2% | 4,635,745 | +21.8% | 0.91% | -31.7% |
| Q2 2017 | $10,501,000 | +41.5% | 3,804,745 | 0.0% | 1.33% | +39.9% |
| Q1 2017 | $7,419,000 | +519.3% | 3,804,745 | +233.4% | 0.95% | +291.7% |
| Q4 2016 | $1,198,000 | -26.7% | 1,141,149 | +107.2% | 0.24% | -78.2% |
| Q4 2014 | $1,635,000 | – | 550,670 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |